Since 1963, Cook Group companies have been among the leaders in developing healthcare devices that have improved lives around the world. COOK remains at the forefront of medical research and worldwide sales of products for endovascular therapy, critical care medicine, general surgery, diagnostic and interventional procedures, bioengineered tissue replacement and regeneration, gastroenterology and endoscopy procedures, urology, and obstetrics and gynecology.
Established in 2004, Kingfisher International Inc. is a veterinary contract research and consulting company in the Greater Toronto Area (GTA). KFI conducts GLP/GCP, regulatory and exploratory research for the pharmaceutical, biologic, and medical devices industries worldwide. KFI is dedicated to animal welfare.
At Teva Canada, we believe that all Canadians deserve access to innovative and affordable medications. We develop, produce and market generic pharmaceuticals, from diabetic agents to antibiotics, from heart medications to cancer treatments. We’ve been part of Canadian healthcare since 1965, when we began operations as one of the country’s first generic pharmaceutical companies. We invest in facilities in this country—creating generic and brand-name medications.